NCT00040937 · OUTCOME

Assess Toxicity of Thalidomide/Dexamethasone as a Pre-transplant Induction Regimen.

S0204 Thalidomide, Chemotherapy, and Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma · Source last updated 2016-12-08

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

What was measured

To assess Grade 3-5 AE related to thalidomide/dexamethasone when administered as a pre-transplant induction regimen.

Analysis population: All participants receiving at least one dose of induction therapy

Not reported

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

Group	Source count
Induction/PBSC Mobilization	140

Source class 1

Values in Participants · Interval/dispersion: Not reported
Group	Value	Spread	Lower	Upper	Comment
Induction/PBSC Mobilization	2	Not reported	Not reported	Not reported	Not reported

Complete source fields

classes

denoms

description

To assess Grade 3-5 AE related to thalidomide/dexamethasone when administered as a pre-transplant induction regimen.

groups

param Type

NUMBER

population Description

All participants receiving at least one dose of induction therapy

reporting Status

POSTED

time Frame

Induction

title

Assess Toxicity of Thalidomide/Dexamethasone as a Pre-transplant Induction Regimen.

type

SECONDARY

unit Of Measure

Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice